Serum total antioxidant capacity in patients with multiple sclerosis

Bosnian Journal of Basic Medical Sciences

Volumn 11, Issue 1, 2011, Pages 33-36

  Hadžović Džuvo, Almira ^a   Lepara, Orhan ^a   Valjevac, Amina ^a   Avdagić, Nesina ^a   Hasić, Sabaheta ^a   Kiseljaković, Emina ^a   Ibragić, Saida ^b   Alajbegović, Azra ^a  

^a UNIVERSITY OF SARAJEVO   (Bosnia and Herzegovina)

^b Institute of Public Health   (Bosnia and Herzegovina)

Author keywords

Multiple sclerosis; Oxidative stress; Total antioxidant capacity (TAC)

Indexed keywords

EID: 79952126397     PISSN: 15128601     EISSN: 18404812     Source Type: Journal    
DOI: 10.17305/bjbms.2011.2620     Document Type: Article

References (19)

1. Mahad D, Ziabreva I, Lassmann H, Turnbull D. Mitochondrial defects in acute multiple sclerosis lesions. Brain 2008; 131(7): 1722-1735.
2. Schreibelt G, van Horssen J, van Rossum S, Dijkstra CD, Drukarch B, de Vries HE. Therapeutic potential and biological role of endogenous antioxidant enzymes in multiple sclerosis pathology. Brain Res Rev 2007; 56(2): 322-330.
3. Uttara B, Singh AV, Zamboni P, Mahajan RT. Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol 2009; 7(1): 65-74.
4. Gilgun-Sherki Y, Melamed E, Offen D. The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy. J Neurol 2004; 251(3): 261-268.
5. Besler HT, Comoǧlu S. Lipoprotein oxidation, plasma total antioxidant capacity and homocysteine level in patients with multiple sclerosis. Nutr Neurosci 2003; 6(3): 189-196.
6. Poser CM, Pety DW, McDonald WJ, Scheinberg L, Ebers CG. New Diagnostic Criteria for Multiple Sclerosis, Guidelines for Research Protocols. Ann Neurol 1983; 13(3): 227-231.
7. Kurtzke JF. Rating neurological impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 1983; 33(11): 1444-1452.
8. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12(3): 189-198.
9. van Horssen J, Schreibelt G, Drexhage J, Hazes T, Dijkstra CD, van der Valk P, de Vries HE. Severe oxidative damage in multiple sclerosis lesions coincides with enhanced antioxidant enzyme expression. Free Radic Biol Med 2008; 45(12): 1729-1737.
10. Carlson NG, Rose JW. Antioxidants in multiple sclerosis: do they have a role in therapy? CNS Drugs 2006; 20(6): 433-441.
11. Mirshafiey A, Mohsenzadegan M. Antioxidant therapy in multiple sclerosis. Immunopharmacol Immunotoxicol 2009; 31(1): 13-29.
12. Besler HT, Comoǧlu S, Okçu Z. Serum levels of antioxidant vitamins and lipid peroxidation in multiple sclerosis. Nutr Neurosci 2002; 5(3): 215-220.
13. Jackson MJ, Papa S, Bolaños J, Bruckdorfer R, Carlsen H, Elliott RM, et al. Antioxidants, reactive oxygen and nitrogen species, gene induction and mitochondrial function. Mol Aspects Med 2002; 23(1-3): 209-285.
14. Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V, Milner A. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci. 1993; 84(4): 407-412.
15. Vinychuk SM, Donchenko GV, Morosova RP, Kopchak OO, Pasechnaya EP, Silonov SB. Prooxidant-antioxidant disbalance in multiple sclerosis and its role in the development of fatigue in patients. Ukrainian Med J 2004; 6(44): 11-12.
16. Karg E, Klivényi P, Németh I, Bencsik K, Pintér S, Vécsei L. Non-enzymatic antioxidants of blood in multiple sclerosis. J Neurol 1999; 246(7): 533-539.
17. Wong EK Jr, Enomoto H, Leopold IH, Williams JL, Kladde L, Hollander DH. Intestinal absorption of dietary fat in patients with multiple sclerosis. Metab Pediatr Syst Ophthalmol 1993; 16(3-4): 39-42.
18. de Bustos F, Jiménez-Jiménez FJ, Molina JA, Gómez-Escalonilla C, de Andrés C, del Hoyo P, et al. Z Serum levels of coenzyme Q10 in patients with multiple sclerosis. Acta Neurol Scand 2000; 101(3): 209-211.
19. Sapcanin A, Sofic E, Tahirovic I, Gavrankapetanovic I, Kalcher K. Antioxidant capacity in the lipophilic fraction of Alzheimer's brain tissues. Bosn J Basic Med Sci 2007; 7(4): 317-332.